News Announcement

Jenburkt Pharmaceuticals: Reg. 34 (1) Annual Report.

Submission of the Annual Report for the FY 2025-26 containing Audited Standalone Financial Statements Auditors Report and Directors Report and the Notice convening 41st Annual General Meeting of the Company.

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan